Vaxart Inc logo

Vaxart Inc

$ 1.99 -0.15 (-7.01%) 10:09 PM EST
P/E:
At Loss
P/B:
1.74
Market Cap:
$ 251.75M
Enterprise V:
$ 153.86M
Volume:
4.64M
Avg Vol (2M):
2.78M
Also Trade In:
Volume:
4.64M
Market Cap $:
251.75M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.78M
Enterprise Value $:
153.86M
PB Ratio:
1.74
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 10.22
Equity-to-Asset 0.79
Debt-to-Equity 0.09
Debt-to-EBITDA -0.15
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.27
Distress
Grey
Safe
Beneish M-Score -5.27
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 27.84
9-Day RSI 29.55
14-Day RSI 30.5
6-1 Month Momentum % -45.31
12-1 Month Momentum % -61.41

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.65
Quick Ratio 8.65
Cash Ratio 8.13
Days Sales Outstanding 233.64

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -160.1

Financials (Next Earnings Date:2022-11-04 Est.)

VXRT's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:VXRT

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.359
EPS (TTM) ($) -0.74
Beta 0.96
Volatility % 53.98
14-Day RSI 30.5
14-Day ATR ($) 0.194438
20-Day SMA ($) 2.3565
12-1 Month Momentum % -61.41
52-Week Range ($) 1.97 - 8.13
Shares Outstanding (Mil) 126.51

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Vaxart Inc Filings

Document Form Filing Date
No Filing Data

Vaxart Inc Analysis

Share your research

Headlines

See More
No news.